|
1
|
Luetke A, Meyers PA, Lewis I and Juergens
H: Osteosarcoma treatment - where do we stand? A state of the art
review. Cancer Treat Rev. 40:523–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Landis SH, Murray T, Bolden S and Wingo
PA: Cancer statistics, 1998. CA Cancer J Clin. 48:6–29. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang J, Zhang L, Qu R and Huang W: Rho A
regulates epidermal growth factor-induced human osteosarcoma MG63
cell migration. Int J Mol Sci. 19:14372018. View Article : Google Scholar
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao GS, Zhang Q, Cao Y, Wang Y, Lv YF,
Zhang ZS, Zhang Y, Tan QL, Chang Y, Quan XZ, et al: High expression
of ID1 facilitates metastasis in human osteosarcoma by regulating
the sensitivity of anoikis via PI3K/AKT depended suppression of the
intrinsic apoptotic signaling pathway. Am J Transl Res.
11:2117–2139. 2019.PubMed/NCBI
|
|
6
|
Briccoli A, Rocca M, Salone M, Guzzardella
GA, Balladelli A and Bacci G: High grade osteosarcoma of the
extremities metastatic to the lung: Long-term results in 323
patients treated combining surgery and chemotherapy, 1985–2005.
Surg Oncol. 19:193–199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results Program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao GS, Gao ZR, Zhang Q, Tang XF, Lv YF,
Zhang ZS, Zhang Y, Tan QL, Peng DB, Jiang DM and Guo QN: TSSC3
promotes autophagy via inactivating the Src-mediated PI3K/Akt/mTOR
pathway to suppress tumorigenesis and metastasis in osteosarcoma,
and predicts a favorable prognosis. J Exp Clin Cancer Res.
37:1882018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu JL, Li J, Xu JJ, Xiao F, Cui PL, Qiao
ZG, Chen XD, Tao WD and Zhang XL: MiR-144 Inhibits Tumor Growth and
Metastasis in Osteosarcoma via Dual-suppressing RhoA/ROCK1
Signaling Pathway. Mol Pharmacol. 95:451–461. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin H, Hao Y, Zhao Z and Tong Y: Sirtuin 6
contributes to migration and invasion of osteosarcoma cells via the
ERK1/2/MMP9 pathway. FEBS Open Bio. 7:1291–1301. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hotfilder M, Baxendale S, Cross MA and
Sablitzky F: Def-2, −3, −6 and −8, novel mouse genes differentially
expressed in the haemopoietic system. Br J Haematol. 106:335–344.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Z, Yang M, Chen R, Su W, Li P, Chen
S, Chen Z, Chen A, Li S and Hu C: IBP regulates
epithelial-to-mesenchymal transition and the motility of breast
cancer cells via Rac1, RhoA and Cdc42 signaling pathways. Oncogene.
33:3374–3382. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Manni M, Ricker E and Pernis AB:
Regulation of systemic autoimmunity and CD11c(+) Tbet(+) B cells by
SWEF proteins. Cell Immunol. 321:46–51. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Oka T, Ihara S and Fukui Y: Cooperation of
DEF6 with activated Rac in regulating cell morphology. J Biol Chem.
282:2011–2018. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Joshi RN, Binai NA, Marabita F, Sui Z,
Altman A, Heck AJ, Tegnér J and Schmidt A: Phosphoproteomics
reveals regulatory T cell-mediated DEF6 dephosphorylation that
affects cytokine expression in human conventional T cells. Front
Immunol. 8:11632017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Binder N, Miller C, Yoshida M, Inoue K,
Nakano S, Hu X, Ivashkiv LB, Schett G, Pernis A, Goldring SR, et
al: Def6 restrains osteoclastogenesis and inflammatory bone
resorption. J Immunol. 198:3436–3447. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Subramanian S, West RB, Marinelli RJ,
Nielsen TO, Rubin BP, Goldblum JR, Patel RM, Zhu S, Montgomery K,
Ng TL, et al: The gene expression profile of extraskeletal myxoid
chondrosarcoma. J Pathol. 206:433–444. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liew PL, Fang CY, Lee YC, Chen CL and Chu
JS: DEF6 expression in ovarian carcinoma correlates with poor
patient survival. Diagn Pathol. 11:682016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jian CX, Yang MZ, Li P, Xiong J, Zhang ZJ,
Li CJ, Chen A, Hu CM, Zhou JX and Li SH: Ectopically expressed IBP
promotes cell proliferation in oral squamous cell carcinoma. Cancer
Invest. 30:748–756. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Z, Wang Q, Li P, Zhou Y, Li S, Yi W,
Chen A, Kong P and Hu C: Overexpression of the Interferon
regulatory factor 4-binding protein in human colorectal cancer and
its clinical significance. Cancer Epidemiol. 33:130–136. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li P, Zhang Z, Wang Q, Li S, Zhang Y, Bian
X, Chen A and Hu C: The ectopic expression of IFN regulatory factor
4-binding protein is correlated with the malignant behavior of
human breast cancer cells. Int Immunopharmacol. 9:1002–1009. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen S, Han Q, Wang X, Yang M, Zhang Z, Li
P, Chen A, Hu C and Li S: IBP-mediated suppression of autophagy
promotes growth and metastasis of breast cancer cells via
activating mTORC2/Akt/FOXO3a signaling pathway. Cell Death Dis.
4:e8422013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Enneking WF, Spanier SS and Goodman MA: A
system for the surgical staging of musculoskeletal sarcoma. 1980.
Clin Orthop Relat Res. 4–18. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Y, Meng G and Guo QN: Changes in
genomic imprinting and gene expression associated with
transformation in a model of human osteosarcoma. Exp Mol Pathol.
84:234–239. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao Z, Zhao GS, Lv Y, Peng D, Tang X, Song
H and Guo QN: Anoikisresistant human osteosarcoma cells display
significant angiogenesis by activating the Src kinasemediated MAPK
pathway. Oncol Rep. 41:235–245. 2019.PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dai H, Huang Y, Li Y, Meng G, Wang Y and
Guo QN: TSSC3 overexpression associates with growth inhibition,
apoptosis induction and enhances chemotherapeutic effects in human
osteosarcoma. Carcinogenesis. 33:30–40. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Meng G, Lv Y, Dai H, Zhang X and Guo QN:
Epigenetic silencing of methyl-CpG-binding protein 2 gene affects
proliferation, invasion, migration, and apoptosis of human
osteosarcoma cells. Tumour Biol. 35:11819–11827. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lv YF, Yan GN, Meng G, Zhang X and Guo QN:
Enhancer of zeste homolog 2 silencing inhibits tumor growth and
lung metastasis in osteosarcoma. Sci Rep. 5:129992015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo J, Liu Q, Li Z, Guo H, Bai C and Wang
F: miR-222-3p promotes osteosarcoma cell migration and invasion
through targeting TIMP3. Onco Targets Ther. 11:8643–8653. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kunz P, Sähr H, Lehner B, Fischer C,
Seebach E and Fellenberg J: Elevated ratio of MMP2/MMP9 activity is
associated with poor response to chemotherapy in osteosarcoma. BMC
Cancer. 16:2232016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li H, Cui J, Xu B, He S, Yang H and Liu L:
Long non-coding RNA XIST serves an oncogenic role in osteosarcoma
by sponging miR-137. Exp Ther Med. 17:730–738. 2019.PubMed/NCBI
|
|
33
|
Waresijiang N, Sun J, Abuduaini R, Jiang
T, Zhou W and Yuan H: The downregulation of miR125a5p functions as
a tumor suppressor by directly targeting MMP11 in osteosarcoma. Mol
Med Rep. 13:4859–4864. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hirahata M, Osaki M, Kanda Y, Sugimoto Y,
Yoshioka Y, Kosaka N, Takeshita F, Fujiwara F, Kawai A, Ito H, et
al: PAI-1, a target gene of miR-143, regulates invasion and
metastasis by upregulating MMP-13 expression of human osteosarcoma.
Cancer Med. 5:892–902. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fan H, Lu S, Wang S and Zhang S:
Identification of critical genes associated with human osteosarcoma
metastasis based on integrated gene expression profiling. Mol Med
Rep. 20:915–930. 2019.PubMed/NCBI
|
|
36
|
Su Y, Wan D and Song W: Dryofragin
inhibits the migration and invasion of human osteosarcoma U2OS
cells by suppressing MMP-2/9 and elevating TIMP-1/2 through
PI3K/AKT and p38 MAPK signaling pathways. Anticancer Drugs.
27:660–668. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Roberts RD, Lizardo MM, Reed DR, Hingorani
P, Glover J, Allen-Rhoades W, Fan T, Khanna C, Sweet-Cordero EA,
Cash T, et al: Provocative questions in osteosarcoma basic and
translational biology: A report from the children's oncology group.
Cancer. 125:3514–3525. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen Q, Gupta S and Pernis AB: Regulation
of TLR4-mediated signaling by IBP/Def6, a novel activator of Rho
GTPases. J Leukoc Biol. 85:539–543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xu Y, Hou Y, Liu T and Lou G:
Overexpression and clinical significance of IBP in epithelial
ovarian carcinoma. Oncol Lett. 15:6604–6610. 2018.PubMed/NCBI
|
|
40
|
Wang SW, Liu SC, Sun HL, Huang TY, Chan
CH, Yang CY, Yeh HI, Huang YL, Chou WY, Lin YM and Tang CH:
CCL5/CCR5 axis induces vascular endothelial growth factor-mediated
tumor angiogenesis in human osteosarcoma microenvironment.
Carcinogenesis. 36:104–114. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xu X, Shuen WH, Chen C, Goudevenou K,
Jones P and Sablitzky F: Swap70b is required for convergent and
extension cell movement during zebrafish gastrulation linking Wnt11
signalling and RhoA effector function. Dev Biol. 386:191–203. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Goudevenou K, Martin P, Yeh YJ, Jones P
and Sablitzky F: Def6 is required for convergent extension
movements during zebrafish gastrulation downstream of Wnt5b
signaling. PLoS One. 6:e265482011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang M, Yuan F, Li P, Chen A, Li S and Hu
C: Interferon regulatory factor 4 binding protein is a novel p53
target gene and suppresses cisplatin-induced apoptosis of breast
cancer cells. Mol Cancer. 11:542012. View Article : Google Scholar : PubMed/NCBI
|
